Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.

Vaccine - 25 Mar 2008

Jadhao Samadhan J, Achenbach Jenna, Swayne David E, Donis Ruben, Cox Nancy, Matsuoka Yumiko

Abstract excerpt

Avian-to-human transmission of the high pathogenicity (HP) H7N7 subtype avian influenza viruses in the Netherlands during 2003 caused zoonotic infections in 89 people, including a case of acute fatal respiratory distress syndrome. Public health emergency preparedness against H7N7 avian influenza viruses with pandemic potential includes the development of vaccine candidate viruses. In order to develop a high...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Viral
Share to Antibody Specificity

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross Reactions

Share to Ferrets

Share to Influenza, Human

Share to Influenza Vaccines

Share to Reassortant Viruses

Share to Vaccines, Inactivated

Source

Identifiers

PMID: 18336962
DOI: 10.1016/j.vaccine.2008.01.036

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of Eurasian H7N7/PR8 high growth reassortant virus for clinical evaluation as an inactivated pandemic influenza vaccine.PMID 18336962Read ↗

Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in FerretsSemantic proximity Read ↗

A Live Attenuated H7N7 Candidate Vaccine Virus Induces Neutralizing Antibody That Confers Protection from Challenge in Mice, Ferrets, and MonkeysSemantic proximity Read ↗

Analysis by Single-Gene Reassortment Demonstrates that the 1918 Influenza Virus Is Functionally Compatible with a Low-Pathogenicity Avian Influenza Virus in MiceSemantic proximity Read ↗

Development of a new candidate H5N1 avian influenza virus for pre‐pandemic vaccine productionSemantic proximity Read ↗

A live attenuated cold-adapted influenza A H7N3 virus vaccine provides protection against homologous and heterologous H7 viruses in mice and ferrets.Semantic proximity Read ↗

Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virusSemantic proximity Read ↗

Molecular Determinants of Adaptation of Highly Pathogenic Avian Influenza H7N7 Viruses to Efficient Replication in the Human HostSemantic proximity Read ↗

Evaluation of Replication and Pathogenicity of Avian Influenza A H7 Subtype Viruses in a Mouse ModelSemantic proximity Read ↗

Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.Semantic proximity Read ↗

Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strainSemantic proximity Read ↗

Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.Semantic proximity Read ↗

Vaccines Developed for H5 Highly Pathogenic Avian Influenza in ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.